Additional file 2: of Long-term safety and effectiveness of a continuous erythropoietin receptor activator (CERA) in patients with renal anemia: a prospective, observational, multicenter study

TSAT and ferritin levels, by disease stage and prior treatment. These tables provide baseline, week 24 and 52 TSAT and ferritin levels according to disease stage and history of ESA administration. (DOCX 23 kb)